Skip to main content
SpringerLink
Log in

Peritonealkarzinose und Erkrankungen des Peritoneums

  • Living reference work entry
  • First Online:
Viszeral- und Allgemeinchirurgie

Part of the book series: Springer Reference Medizin ((SRM))

  • 53 Accesses

Zusammenfassung

Die multimodale Therapie, bestehend aus zytoreduktiver Chirurgie (CRS) in Kombination mit hyperthermer intraperitonealer Chemotherapie (HIPEC) und systemischer Therapie, ist eine Therapieoption für Patienten mit primär peritonealen Neoplasien und Patienten mit sekundärer peritonealer Metastasierung.

Entscheidend für die Prognose ist neben der Qualität der operativen Therapie vor allem eine sorgfältige Patientenselektion. Durch die Auswahl geeigneter Patienten und die Anwendung standardisierter Operationstechniken kann das Gesamtüberleben im Vergleich zur alleinigen systemischen Therapie signifikant verlängert werden. Nach mehr als 3 Jahrzehnten klinischer Anwendung sind die Selektionskriterien für die einzelnen Tumorentitäten inzwischen gut definiert, das Therapieverfahren standardisiert und Komplikationsraten niedrig.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Similar content being viewed by others

Literatur

  • Bao P et al (2009) Surgical techniques in visceral resection and peritonectomy procedures. Cancer J 15(3):204–211

    Article  PubMed  Google Scholar 

  • Baratti D et al (2012) Cytoreductive surgery with selective versus complete parietal peritonectomy followed by hyperthermic intraperitoneal chemotherapy in patients with diffuse malignant peritoneal mesothelioma: a controlled study. Ann Surg Oncol 19(5):1416–1424

    Article  PubMed  Google Scholar 

  • Baratti D et al (2016) Pseudomyxoma peritonei of extra-appendiceal origin: a comparative study. Ann Surg Oncol 23(13):4222–4230

    Article  PubMed  Google Scholar 

  • Baron E et al (2020) Pelvic anastomosis without protective ileostomy is safe in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 27(13):4931–4940

    Article  PubMed  Google Scholar 

  • Beckert S et al (2015) Overall morbidity but not mortality is increased in elderly patients following cytoreductive surgery and HIPEC. Langenbeck’s Arch Surg/Dtsch Ges Chir 400(6):693–698

    Google Scholar 

  • Bhatt A et al (2016) Cytoreductive surgery plus HIPEC for peritoneal metastases from colorectal cancer. Indian J Surg Oncol 7(2):177–187

    Article  PubMed  PubMed Central  Google Scholar 

  • Bijelic L et al (2008) Cytoreduction of the small bowel surfaces. J Surg Oncol 97(2):176–179

    Article  PubMed  Google Scholar 

  • Boffetta P (2007) Epidemiology of peritoneal mesothelioma: a review. Ann Oncol 18(6):985–990

    Article  CAS  PubMed  Google Scholar 

  • Barrios, P et al (2012) Safe anastomoses without ostomies in cytoreductive surgery with heated intraperitoneal chemotherapy: technical considerations and modifications. Ann Surg Oncol 28(12):7784–7792

    Google Scholar 

  • Brandl A et al (2018) Safety of extraperitoneal rectal resection and ileo- or colorectal anastomosis without loop ileostomy in patients with peritoneal metastases treated with CRS and HIPEC. Colorectal Dis: Online ahead of print

    Google Scholar 

  • Brandl A et al (2021) Long term survival in patients with peritoneal metastasised gastric cancer treated with cytoreductive surgery and HIPEC: a multi-institutional cohort from PSOGI. Eur J Surg Oncol 47(1):172–180

    Article  PubMed  Google Scholar 

  • Brucher BL et al (2012) Peritoneal carcinomatosis: cytoreductive surgery and HIPEC – overview and basics. Cancer Investig 30(3):209–224

    Article  Google Scholar 

  • Carr NJ et al (2016) A consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: the results of the peritoneal surface oncology group international (PSOGI) modified delphi process. Am J Surg Pathol 40(1):14–26

    Article  PubMed  Google Scholar 

  • Carteni G et al (2009) Malignant peritoneal mesothelioma-results from the international expanded access program using pemetrexed alone or in combination with a platinum agent. Lung Cancer 64(2):211–218

    Article  CAS  PubMed  Google Scholar 

  • Ceelen WP et al (2010) Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence. Nat Rev Clin Oncol 7(2):108–115

    Article  PubMed  Google Scholar 

  • Chia CS et al (2014) Quality of life in patients with peritoneal surface malignancies after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Eur J Surg oncol 40(8):909–916

    Article  CAS  PubMed  Google Scholar 

  • Chia CS et al (2016) Patients with peritoneal carcinomatosis from gastric cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: is cure a possibility? Ann Surg Oncol 23(6):1971–1979

    Google Scholar 

  • Choudry HA et al (2018) Management of mucinous appendiceal tumors. Ann Surg Oncol 25(8):2135–2144

    Article  PubMed  Google Scholar 

  • Chouliaras K et al (2017) Prognostic Factors and Significance of Gastrointestinal Leak After Cytoreductive Surgery (CRS) with Heated Intraperitoneal Chemotherapy (HIPEC). Ann Surg Oncol 24(4):890–897

    Article  PubMed  Google Scholar 

  • Chua TC et al (2012) Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol Off J Am Soc Clin Oncol 30(20):2449–2456

    Article  Google Scholar 

  • Coccolini F et al (2014) Intraperitoneal chemotherapy in advanced gastric cancer. Meta-analysis of randomized trials. Eur J Surg Oncol 40(1):12–26

    Article  CAS  PubMed  Google Scholar 

  • Dagbert F et al (2016) Splenectomy increases postoperative complications following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 23(6):980–1985

    Google Scholar 

  • D’Angelica M et al (2004) Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg 240(5):808–816

    Article  PubMed  PubMed Central  Google Scholar 

  • Davison JM et al (2014) Clinicopathologic and molecular analysis of disseminated appendiceal mucinous neoplasms: identification of factors predicting survival and proposed criteria for a three-tiered assessment of tumor grade. Mod Pathol 27(11):1521–1539

    Article  PubMed  Google Scholar 

  • Delhorme JB et al (2018) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendicular and extra-appendicular origin. Br J Surg 105(6):668–676

    Article  PubMed  Google Scholar 

  • Desolneux G et al (2015) Cytoreductive surgery of colorectal peritoneal metastases: outcomes after complete cytoreductive surgery and systemic chemotherapy only. PloS one 10(3):e0122816

    Article  PubMed  PubMed Central  Google Scholar 

  • Dizon DS et al (2016) Clinical cancer advances 2016: annual report on progress against cancer from the American Society of Clinical Oncology. J Clin Oncol 34(9):987–1011

    Article  CAS  PubMed  Google Scholar 

  • Doud AN et al (2016) Stoma creation and reversal after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 23(2):503–510

    Article  PubMed  Google Scholar 

  • Driel WJ van et al (2018) Hyperthermic intraperitoneal chemotherapy in ovarian cancer. N Engl J Med 378(3):230–240

    Google Scholar 

  • Elias D et al (2002) Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution. Ann Oncol 13(2):267–272

    Article  CAS  PubMed  Google Scholar 

  • Elias D et al (2004) Treatment of peritoneal carcinomatosis from colorectal cancer: impact of complete cytoreductive surgery and difficulties in conducting randomized trials. Ann Surg Oncol 11(5):518–521

    Article  PubMed  Google Scholar 

  • Elias D et al (2009) Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol Off J Am Soc Clin Oncol 27(5):681–685

    Article  Google Scholar 

  • Elias D et al (2010) Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol Off J Am Soc Clin Oncol 28(1):63–68

    Article  Google Scholar 

  • Esquivel J et al (2007) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of surgical oncology. Ann Surg Oncol 14(1):128–133

    Article  CAS  PubMed  Google Scholar 

  • Ezzedine W et al (2021) Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for resectable peritoneal metastases is feasible in elderly patients. Updates Surg 73(2):719–730

    Google Scholar 

  • Fallis SA et al (2015) Management of pseudomyxoma peritonei. J BUON 20(Suppl 1):S47–S55

    PubMed  Google Scholar 

  • Faron M et al (2015) Linear relationship of peritoneal cancer index and survival in patients with peritoneal metastases from colorectal cancer. Ann Surg Oncol 23(1):14–119

    Google Scholar 

  • Foster JM et al (2016) Early identification of DPAM in at-risk low-grade appendiceal mucinous neoplasm patients: a new approach to surveillance for peritoneal metastasis. World J Surg Oncol 14(1):243

    Article  PubMed  PubMed Central  Google Scholar 

  • Foster JM et al (2019) Morbidity and mortality rates following cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy compared with other high-risk surgical oncology procedures. JAMA Netw Open 2(1):e186847

    Article  PubMed  PubMed Central  Google Scholar 

  • Fournier K et al (2017) Low-grade appendiceal mucinous neoplasm of uncertain malignant potential (LAMN-UMP): prognostic factors and implications for treatment and follow-up. Ann Surg Oncol 24(1):187–193

    Article  PubMed  Google Scholar 

  • Garofalo A et al (2009) Laparoscopy in the management of peritoneal carcinomatosis. Cancer J 15(3):190–195

    Article  PubMed  Google Scholar 

  • Glehen O et al (2010a) Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients. Cancer 116(24):5608–5618

    Article  PubMed  Google Scholar 

  • Glehen O et al (2010b) Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol 17(9):2370–2377

    Article  PubMed  Google Scholar 

  • Goere D et al (2013) Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy? Ann Surg 257(6):1065–1071

    Article  PubMed  Google Scholar 

  • Guaglio M et al (2018) Clinical surveillance after macroscopically complete surgery for low-grade appendiceal mucinous neoplasms (LAMN) with or without limited peritoneal spread: long-term results in a prospective series. Ann Surg Oncol 25(4):878–884

    Google Scholar 

  • Hentzen J et al (2020) Diagnostic laparoscopy as a selection tool for patients with colorectal peritoneal metastases to prevent a non-therapeutic laparotomy during cytoreductive surgery. Ann Surg Oncol 27(4):1084–1093

    Article  PubMed  Google Scholar 

  • Hompes D et al (2012) The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study. Ann Surg Oncol 19(7):2186–2194

    Article  PubMed  Google Scholar 

  • Hugen N et al (2014) Metastatic pattern in colorectal cancer is strongly influenced by histological subtype. Ann Oncol 25(3):651–657

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ikoma N et al (2016) Yield of staging laparoscopy and lavage cytology for radiologically occult peritoneal carcinomatosis of gastric cancer. Ann Surg Oncol 23(13):4332–4337

    Article  PubMed  Google Scholar 

  • Ikoma N et al (2017) Patterns of initial recurrence in gastric adenocarcinoma in the era of preoperative therapy. Ann Surg Oncol 24(9):2679–2687

    Article  PubMed  Google Scholar 

  • Iversen LH et al (2013) Value of laparoscopy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis. Br J Surg 100(2):285–292

    Article  CAS  PubMed  Google Scholar 

  • Jarvinen P et al (2013) Feasibility of radical cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendiceal origin. Scand J Surg 102(3):145–151

    Article  CAS  PubMed  Google Scholar 

  • Jayakrishnan TT et al (2014) Role of laparoscopy in patients with peritoneal metastases considered for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). World J Surg Oncol 12:270

    Article  PubMed  PubMed Central  Google Scholar 

  • Jimenez W et al (2014) Predictive and prognostic survival factors in peritoneal carcinomatosis from appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 21(13):4218–4225

    Google Scholar 

  • Kim J et al (2017) Malignant peritoneal mesothelioma: a review. Ann Transl Med 5(11):236

    Article  PubMed  PubMed Central  Google Scholar 

  • Kobayashi H et al (2014) Outcomes of surgery without HIPEC for synchronous peritoneal metastasis from colorectal cancer: data from a multi-center registry. Int J Clin Oncol 19(1):98–105

    Article  PubMed  Google Scholar 

  • Koh JL et al (2009) Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis. Ann Surg Oncol 16(2):327–333

    Article  PubMed  Google Scholar 

  • Kusamura S et al (2016) The role of Ki-67 and pre-cytoreduction parameters in selecting Diffuse Malignant Peritoneal Mesothelioma (DMPM) Patients for Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC). Ann Surg Oncol 23(5):1468–1473

    Article  PubMed  Google Scholar 

  • Kwakman R et al (2016) Clinicopathological parameters in patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer metastases: a meta-analysis. Ann Surg 263(6):1102–1111

    Google Scholar 

  • Leimkuhler M et al (2020) Systematic review of factors affecting quality of life after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 27(10):3973–3983

    Article  PubMed  PubMed Central  Google Scholar 

  • Lima Vazquez V de et al (2003) Extent of parietal peritonectomy does not change intraperitoneal chemotherapy pharmacokinetics. Cancer Chemother Pharmacol 52(2):108–112

    Google Scholar 

  • MacArthur KM et al (2013) Principles and innovations in peritoneal surface malignancy treatment. World J Oncol 4(3):129–136

    PubMed  PubMed Central  Google Scholar 

  • Maciver AH et al (2017) Current delivery of hyperthermic intraperitoneal chemotherapy with cytoreductive surgery (CS/HIPEC) and perioperative practices: an international survey of high-volume surgeons. Ann Surg Oncol 24(4):923–930

    Article  PubMed  Google Scholar 

  • Marin D et al (2010) 64-Section multi-detector row CT in the preoperative diagnosis of peritoneal carcinomatosis: correlation with histopathological findings. Abdom Imaging 35(6):694–700

    Article  PubMed  Google Scholar 

  • McQuellon RP et al (2001) Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis. Eur J Surg Oncol 27(1):65–73

    Article  CAS  PubMed  Google Scholar 

  • McQuellon RP et al (2003) Long-term survivorship and quality of life after cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis. Ann Surg Oncol 10(2):155–162

    Article  PubMed  Google Scholar 

  • Mohkam K et al (2016) Resectability of peritoneal carcinomatosis: learnings from a prospective cohort of 533 consecutive patients selected for cytoreductive surgery. Ann Surg Oncol 23(4):1261–1270

    Article  PubMed  Google Scholar 

  • Moran B et al (2015) The results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1200 patients with peritoneal malignancy. Color Dis 17(9):772–778

    Article  CAS  Google Scholar 

  • Munoz-Zuluaga CA et al (2020) Defining „Complete Cytoreduction“ After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) for the histopathologic spectrum of appendiceal carcinomatosis. Ann Surg Oncol 27(13):5026–5036

    Article  PubMed  Google Scholar 

  • Narasimhan V et al (2020) Prognostic factors influencing survival in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for isolated colorectal peritoneal metastases: a systematic review and meta-analysis. Color Dis 22(11):1482–1495

    Article  CAS  Google Scholar 

  • Oudheusden TR van et al (2015) Peritoneal cancer patients not suitable for cytoreductive surgery and HIPEC during explorative surgery: risk factors, treatment options, and prognosis. Ann Surg Oncol 22(4):1236–1242

    Google Scholar 

  • Pai RK et al (2009) Appendiceal mucinous neoplasms: clinicopathologic study of 116 cases with analysis of factors predicting recurrence. Am J Surg Pathol 33(10):1425–1439

    Article  PubMed  Google Scholar 

  • Passot G et al (2014) Quality of life after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy: a prospective study of 216 patients. Eur J Surg Oncol 40(5):529–535

    Article  CAS  PubMed  Google Scholar 

  • Passot G et al (2016) Digital glissonectomy: a safe perihepatic peritonectomy. Ann Surg Oncol 23(12):3978–3985

    Google Scholar 

  • Passot G et al (2018) Multicentre study of laparoscopic or open assessment of the peritoneal cancer index (BIG-RENAPE). Br J Surg 105(6):663–667

    Article  CAS  PubMed  Google Scholar 

  • Pelz JO et al (2007) Hyperthermic intraperitoneal chemoperfusion (HIPEC) decrease wound strength of colonic anastomosis in a rat model. Int J Color Dis 22(8):941–947

    Article  CAS  Google Scholar 

  • Polanco PM et al (2015) Institutional learning curve of cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for peritoneal malignancies. Ann Surg Oncol 22(5):1673–1679

    Article  PubMed  Google Scholar 

  • Quenet F et al (2011) Results of two bi-institutional prospective studies using intraperitoneal oxaliplatin with or without irinotecan during HIPEC after cytoreductive surgery for colorectal carcinomatosis. Ann Surg 254(2):294–301

    Article  PubMed  Google Scholar 

  • Quenet F et al (2021) Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol 22(2):256–266

    Article  CAS  PubMed  Google Scholar 

  • Rivard JD et al (2014) Preoperative computed tomography does not predict resectability in peritoneal carcinomatosis. Am J Surg 207(5):760–764; discussion 764–765

    Article  PubMed  Google Scholar 

  • Sato H et al (2016) Clinicopathological factors associated with recurrence and prognosis after R0 resection for stage IV colorectal cancer with peritoneal metastasis. Dig Surg 33(5):382–391

    Article  CAS  PubMed  Google Scholar 

  • Schaaf L et al (2015) A temperature of 40 degrees C appears to be a critical threshold for potentiating cytotoxic chemotherapy in vitro and in peritoneal carcinomatosis patients undergoing HIPEC. Ann Surg Oncol 22(Suppl 3):758–765

    Article  Google Scholar 

  • Seshadri RA et al (2016) The role of hyperthermic intraperitoneal chemotherapy in gastric cancer. Indian J Surg Oncol 7(2):198–207

    Article  PubMed  PubMed Central  Google Scholar 

  • Shabbir J et al (2010) Stoma complications: a literature overview. Color Dis 12(10):958–964

    Article  CAS  Google Scholar 

  • Shida D et al (2018a) Prognostic impact of R0 resection and targeted therapy for colorectal cancer with synchronous peritoneal metastasis. Ann Surg Oncol 25(6):1646–1653

    Article  PubMed  Google Scholar 

  • Shida D et al (2018b) Long-term outcomes after R0 resection of synchronous peritoneal metastasis from colorectal cancer without cytoreductive surgery or hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 25(1):173–178

    Article  PubMed  Google Scholar 

  • Somashekhar SP et al (2019) Impact of extent of parietal peritonectomy on oncological outcome after cytoreductive surgery and HIPEC. Pleura Peritoneum 4(4):20190015

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Spolverato G et al (2014) Rates and patterns of recurrence after curative intent resection for gastric cancer: a united states multi-institutional analysis. J Am Coll Surg 219(4):664–675

    Article  PubMed  Google Scholar 

  • Sugarbaker PH (2006) New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol 7(1):69–76

    Article  PubMed  Google Scholar 

  • Sugarbaker PH (2016) Preoperative assessment of cancer patients with peritoneal metastases for complete cytoreduction. Indian J Surg Oncol 7(3):295–302

    Article  PubMed  PubMed Central  Google Scholar 

  • Sugarbaker PH (2018) Update on the management of malignant peritoneal mesothelioma. Transl Lung Cancer Res 7(5):599–608

    Article  PubMed  PubMed Central  Google Scholar 

  • Sugarbaker PH et al (2005) Update on chemotherapeutic agents utilized for perioperative intraperitoneal chemotherapy. Oncologist 10(2):112–122

    Article  CAS  PubMed  Google Scholar 

  • Sugarbaker PH et al (2010) Pharmacologic rationale for treatments of peritoneal surface malignancy from colorectal cancer. World J Gastrointest Oncol 2(1):19–30

    Article  PubMed  PubMed Central  Google Scholar 

  • Tischoff I et al (2017) Mesothelioma. Pathologe 38(6):547–560

    Article  CAS  PubMed  Google Scholar 

  • Tsilimparis N et al (2013) Quality of life in patients after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: is it worth the risk? Ann Surg Oncol 20(1):226–232

    Article  PubMed  Google Scholar 

  • Turaga KK et al (2017) Current management strategies for peritoneal mesothelioma. Int J Hyperth 33(5):579–581

    Article  Google Scholar 

  • Urano M et al (1999) For the clinical application of thermochemotherapy given at mild temperatures. Int J Hyperthermia 15(2):79–107

    Article  CAS  PubMed  Google Scholar 

  • Valle SJ et al (2016) Hyperthermic intraperitoneal chemotherapy (HIPEC) methodology, drugs and bidirectional chemotherapy. Indian J Surg Oncol 7(2):152–159

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Verwaal VJ et al (2003) Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol Off J Am Soc Clin Oncol 21(20):3737–3743

    Article  Google Scholar 

  • Votanopoulos KI et al (2018) PCI is not predictive of survival after complete CRS/HIPEC in peritoneal dissemination from high-grade appendiceal primaries. Ann Surg Oncol 25(3):674–678

    Article  PubMed  Google Scholar 

  • Wiseman JT et al (2020) Predictors of anastomotic failure after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: does technique matter? Ann Surg Oncol 27(3):783–792

    Article  PubMed  Google Scholar 

  • Yan TD et al (2007a) A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer. Ann Surg Oncol 14(10):2702–2713

    Article  PubMed  Google Scholar 

  • Yan TD et al (2007b) Learning curve for cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal surface malignancy – a journey to becoming a Nationally Funded Peritonectomy Center. Ann Surg Oncol 14(8):2270–2280

    Article  PubMed  Google Scholar 

  • Yan TD et al (2009) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol Off J Am Soc Clin Oncol 27(36):6237–6242

    Article  Google Scholar 

  • Yang XJ et al (2011) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol 18(6):1575–1581

    Article  PubMed  PubMed Central  Google Scholar 

  • Yantiss RK et al (2009) Prognostic significance of localized extra-appendiceal mucin deposition in appendiceal mucinous neoplasms. Am J Surg Pathol 33(2):248–255

    Article  PubMed  Google Scholar 

  • Yonemura Y et al (2005) Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion. Br J Surg 92(3):370–375

    Article  CAS  PubMed  Google Scholar 

  • Yonemura Y et al (2009) Safety and efficacy of bidirectional chemotherapy for treatment of patients with peritoneal dissemination from gastric cancer: selection for cytoreductive surgery. J Surg Oncol 100(4):311–316

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Krankenhaus Barmherzige Brüder Regensburg, Regensburg, Deutschland

    Hubert Leebmann & Pompiliu Piso

Authors
  1. Hubert Leebmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pompiliu Piso
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hubert Leebmann .

Editor information

Editors and Affiliations

  1. Allgemein- Viszeral- u. Gefäßchirurgie, Charité Universitätsmedizin Berlin, Berlin, Berlin, Deutschland

    Martin Kreis

  2. Klinik für Visceral-, Thorax- und G, Universitätsklinikum Marburg, Marburg, Hessen, Deutschland

    Detlef K. Bartsch

  3. Klinik & Poliklinik Allgemein & Abdomin, Universitätsklinikum Mainz, Mainz, Rheinland-Pfalz, Deutschland

    Hauke Lang

Section Editor information

  1. Charité – Universitätsmedizin Berlin, Berlin, Germany

    Martin Kreis

  2. Klinik für Allgemein-, Viszeral- und Gefäßchirurgie, Charité – Universitätsmedizin Berlin, Berlin, Deutschland

    Katharina Beyer

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Leebmann, H., Piso, P. (2023). Peritonealkarzinose und Erkrankungen des Peritoneums. In: Kreis, M., Bartsch, D.K., Lang, H. (eds) Viszeral- und Allgemeinchirurgie. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-61724-3_61-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-61724-3_61-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-61724-3

  • Online ISBN: 978-3-662-61724-3

  • eBook Packages: Springer Referenz Medizin

Publish with us

Policies and ethics

Search

Navigation